Michael D. West - Jun 11, 2021 Form 4 Insider Report for AgeX Therapeutics, Inc. (AGE)

Role
Chief Executive Officer, Director
Signature
/s/Michael D. West
Stock symbol
AGE
Transactions as of
Jun 11, 2021
Transactions value $
-$1,654
Form type
4
Date filed
6/15/2021, 09:12 PM
Previous filing
Jun 8, 2021
Next filing
Sep 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGE Common Stock, $0.0001 par value Options Exercise $0 +3.13K +9.63% $0.00 35.6K Jun 11, 2021 Direct
transaction AGE Common Stock, $0.0001 par value Tax liability -$1.65K -1.08K -3.04% $1.53 34.5K Jun 11, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGE Restricted Stock Units Options Exercise $0 -3.13K -12.5% $0.00 21.9K Jun 11, 2021 Common Stock 3.13K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 3,125 Restricted Stock Units, the grant of which was previously reported on a Form 4.
F2 Restricted Stock Units vested on June 11, 2021.